RxDoctor Payments DataLook up a doctor →

Sarah Harder

Family · Knoxville, TNNPI 1619410099

Payments from drug & device makers

$19,367in general payments, 2019–2025

Across 815 payments — averaging $23.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AstraZeneca$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Novartis$1K
  • Amgen$870
  • Merck$861
  • plus $13K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson46$1,549
AstraZeneca(2 entities)46$1,219
E.r. Squibb & Sons, L.L.C.43$1,039
Novartis55$1,004
Amgen32$870
Merck38$861
Pfizer41$834
Genentech USA, Inc.35$720
Incyte Corporation26$718
Gilead(2 entities)25$691
Regeneron Healthcare Solutions, Inc.22$647
Sanofi25$639
Bristol Myers Squibb39$610
Astellas Pharma US Inc26$560
Seagen Inc.22$469
AbbVie18$460
Eisai Inc.22$455
GSK21$443
Takeda Pharmaceuticals U.S.A., Inc.19$438
Bayer19$381
Lilly USA, LLC17$355
Puma Biotechnology, Inc.16$337
Karyopharm Therapeutics Inc.11$309
Daiichi Sankyo Inc.11$283
Caris MPI, Inc.9$275
AVEO Pharmaceuticals, Inc.8$262
Array Biopharma Inc8$171
Jazz Pharmaceuticals Inc.4$164
Iovance Biotherapeutics, Inc.2$160
Deciphera Pharmaceuticals Inc.6$156
Exelixis Inc.6$145
Beigene USA, Inc.6$141
Myriad Genetic Laboratories, Inc.7$129
Heron Therapeutics, Inc.1$125
G1 Therapeutics, Inc.5$111
Blueprint Medicines Corporation5$110
Mirati Therapeutics, Inc.4$107
Sobi, Inc5$107
Genmab U.S., Inc.5$105
Boehringer Ingelheim5$104
EMD Serono, Inc.5$102
Servier Pharmaceuticals LLC4$88
Morphosys, US Inc.5$86
Novocure Inc.5$83
Stemline Therapeutics Inc.3$74
Beone Medicines USA, Inc.3$70
Ipsen Biopharmaceuticals, Inc3$63
Tersera Therapeutics LLC3$59
Pharmacosmos Therapeutics Inc.3$55
Springworks Therapeutics, Inc.2$50
Geron Corporation2$49
Taiho Oncology, Inc.3$47
ADC Therapeutics America, Inc.2$41
Kyowa Kirin, Inc.2$37
Janssen Scientific Affairs, LLC1$35
Immunogen, Inc.1$29
Syndax Pharmaceuticals, Inc.1$27
Pharmaessentia USA Corporation1$24
Pharmacyclics LLC, An Abbvie Company1$22
Apellis Pharmaceuticals, Inc.1$20

How this compares

$19,367 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Medicare billing

Part B allowed, 2024
$7,241
Medicare patients
50
Services billed
63

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Knoxville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →